文献速递呼吸道感染呼吸危重症与机械通气

COVID-19相关纵隔气肿:重症肺炎的表型?英国POETIC调查结果

Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the UK POETIC survey.
PubMed 文献 · Eur Respir J · 2022-09-07

英国POETIC调查在2020年9月至2021年2月纳入53家医院58 484例COVID-19住院患者,识别377例纵隔气肿(PTM),发生率0.64%。PTM患者120天死亡率为51.7%(195/377),诊断时45.6%接受机械通气;机械通气是死亡率最重要预测因素(p<0.001),年龄增长(p<0.01)和糖尿病(p=0.08)亦相关。诊断PTM后将持续气道正压改为氧疗或经鼻高流量氧疗与死亡率无差异。

要点

  • COVID-19住院患者中纵隔气肿发生率为0.64%。
  • 纵隔气肿患者120天死亡率达51.7%。
  • 机械通气是纵隔气肿患者死亡率最重要预测因素。

核心结论

  • 纵隔气肿似乎是重症COVID-19肺炎的标志。
  • 多数被识别纵隔气肿的患者在诊断时并未接受机械通气。

研究设计与样本

  • 2020年9月至2021年2月通过英国呼吸研究网络开展的结构化调查。
  • 纳入53家医院58 484例COVID-19住院患者,识别377例经影像学证实的纵隔气肿患者。

主要发现

  • COVID-19住院患者中纵隔气肿发生率为0.64%(377/58 484)。
  • 纵隔气肿患者120天死亡率为51.7%(195/377)。
  • 诊断时45.6%(172/377)的患者接受机械通气。
  • 机械通气是诊断时及之后死亡率的最重要预测因素(p<0.001),年龄增长(p<0.01)和糖尿病(p=0.08)亦相关。
  • 诊断纵隔气肿后将持续气道正压支持改为氧疗或经鼻高流量氧疗与死亡率无差异。

临床怎么用

  • 临床遇到COVID-19肺炎患者出现纵隔气肿时,应认识到其提示重症肺炎且死亡风险高。
  • 纵隔气肿可发生于未接受机械通气的患者,诊断时需评估呼吸支持方式。
  • 诊断纵隔气肿后由持续气道正压改为氧疗或经鼻高流量氧疗与死亡率无差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is an emerging understanding that coronavirus disease 2019 (COVID-19) is associated with increased incidence of pneumomediastinum (PTM). We aimed to determine its incidence among patients hospitalised with COVID-19 in the UK and describe factors associated with outcome. METHODS: A structured survey of PTM and its incidence was conducted from September 2020 to February 2021. UK-wide participation was solicited via respiratory research networks. Identified patients had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and radiologically proven PTM. The primary outcomes were to determine incidence of PTM in COVID-19 and to investigate risk factors associated with patient mortality. RESULTS: 377 cases of PTM in COVID-19 were identified from 58 484 inpatients with COVID-19 at 53 hospitals during the study period, giving an incidence of 0.64%. Overall 120-day mortality in COVID-19 PTM was 195 out of 377 (51.7%). PTM in COVID-19 was associated with high rates of mechanical ventilation. 172 out of 377 patients (45.6%) were mechanically ventilated at the point of diagnosis. Mechanical ventilation was the most important predictor of mortality in COVID-19 PTM at the time of diagnosis and thereafter (p<0.001), along with increasing age (p<0.01) and diabetes mellitus (p=0.08). Switching patients from continuous positive airway pressure support to oxygen or high-flow nasal oxygen after the diagnosis of PTM was not associated with difference in mortality. CONCLUSIONS: PTM appears to be a marker of severe COVID-19 pneumonitis. The majority of patients in whom PTM was identified had not been mechanically ventilated at the point of diagnosis.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Melhorn J, Achaiah A, Conway FM, et al. Pneumomediastinum in COVID-19: a phenotype of severe COVID-19 pneumonitis? The results of the UK POETIC survey. Eur Respir J. 2022. PMID: 35144988. doi:10.1183/13993003.02522-2021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。